Population Pharmacokinetics of Tobramycin Inhalation Solution in Pediatric Patients With Cystic Fibrosis-Reference-Cited by-同舟云学术

Population Pharmacokinetics of Tobramycin Inhalation Solution in Pediatric Patients With Cystic Fibrosis

Published:2017-11 Issue:11 Volume:106 Page:3402-3409
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Wang Xinting,Koehne-Voss Stephan,Anumolu SivaNaga S.,Yu Jing

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference31 articles.

1. Cystic Fibrosis Foundation. 2015. Cystic Fibrosis Foundation Patient Registry 2014 Annual Data Report. Bethesda. Available at: https://www.cff.org/2014_CFF_Annual_Data_Report_to_the_Center_Directors.pdf/. Accessed July 12, 2017.

2. Lung infections associated with cystic fibrosis;Lyczak;Clin Microbiol Rev,2002

3. Tobramycin in treatment of infections due to Pseudomonas aeruginosa in patients with cystic fibrosis;Crozier;J Infect Dis,1976

4. Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis;Shawar;Antimicrob Agents Chemother,1999

5. Cystic fibrosis pulmonary guidelines;Flume;Am J Respir Crit Care Med,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual inhaled antibiotics for treatment of pulmonary exacerbations in cystic fibrosis – A real life pilot study;Respiratory Medicine and Research;2024-11

2. S3-Leitlinie: Lungenerkrankung bei Mukoviszidose – Pseudomonas aeruginosa;Pneumologie;2024-02-13

3. Heterogeneity Governs 3D‐Cultures of Clinically Relevant Microbial Communities;Advanced Functional Materials;2023-08-22

4. Pulmonary bacteriophage and cystic fibrosis airway mucus: friends or foes?;Frontiers in Medicine;2023-05-17

5. Tobramycin safety and efficacy review article;Respiratory Medicine;2022-04